Bill Sponsor
Senate Bill 2901
116th Congress(2019-2020)
Improving Medicare Beneficiary Access to Innovative Diabetes Technologies Act of 2019
Introduced
Introduced
Introduced in Senate on Nov 19, 2019
Overview
Text
Introduced
Nov 19, 2019
Latest Action
Nov 19, 2019
Origin Chamber
Senate
Type
Bill
Bill
The primary form of legislative measure used to propose law. Depending on the chamber of origin, bills begin with a designation of either H.R. or S. Joint resolution is another form of legislative measure used to propose law.
Bill Number
2901
Congress
116
Policy Area
Health
Health
Primary focus of measure is science or practice of the diagnosis, treatment, and prevention of disease; health services administration and funding, including such programs as Medicare and Medicaid; health personnel and medical education; drug use and safety; health care coverage and insurance; health facilities. Measures concerning controlled substances and drug trafficking may fall under Crime and Law Enforcement policy area.
Sponsorship by Party
Republican
Maine
Democrat
New Hampshire
Senate Votes (0)
House Votes (0)
No Senate votes have been held for this bill.
Summary

Improving Medicare Beneficiary Access to Innovative Diabetes Technologies Act of 2019

This bill establishes the Task Force on Innovative Diabetes Technologies and Services to address the accessibility of innovative diabetes technologies and services to Medicare beneficiaries. The bill defines innovative diabetes technologies and services as medical technologies and services for diabetes treatment that are not covered under Medicare.

Among other activities, the task force must (1) recommend ways to improve access to innovative diabetes technologies and services through new or alternative payment models and existing policies, and (2) propose changes to foster collaboration between the Food and Drug Administration and the Centers for Medicare & Medicaid Services to streamline approval and coverage.

Text (1)
November 19, 2019
Actions (2)
11/19/2019
Read twice and referred to the Committee on Finance. (Sponsor introductory remarks on measure: CR S6673)
11/19/2019
Introduced in Senate
Public Record
Record Updated
Oct 28, 2022 2:00:28 AM